Dystrophin expressing chimeric cells(Dystrogen Therapeutics)

N/A

Report date: 2022/01/28 17:51:09

Base Information

Drug NameDystrophin expressing chimeric cells(Dystrogen Therapeutics)
Drug Alias NameDuchenne muscular dystrophy cell therapy ( Dystrogen Therapeutics)DECDT-DEC01DT-DEC-01DTDEC01 +[6] 
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At Chicago
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Illinois At ChicagoDystrogen Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A